1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Primary Mediastinal Lymphoma: new trials by email Literature Review of Primary Mediastinal Lymphoma trials Research Report on Primary Mediastinal Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nivolumab 40 mg in Combination With Chemo-Immunotherapy for Newly Diagnosed Primary Mediastinal B-Cell Lymphoma Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide Phosphate - Primary Mediastinal Lymphoma | Phase 3 | Active not recruiting | National Research Center for Hematology, Russia | 60 | 2022-04-01 | 2026-10-08 |
Cyclophosphamide (1) · Doxorubicin (1) · Filgrastim (1) · Injections (1) · Nivolumab (1) · Prednisolone (1) · Rituximab (1) · Vincristine (1) · etoposide phosphate (1) · pegfilgrastim (1)
National Research Center for Hematology, Russia (1)
Russia (1)